
CASE DISCUSSION
Atrial Fibrillation - A Concise Review
Views
12,481
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by rapid, irregular electrical activity in the atria of the heart. AF is a prevalent condition, affecting millions of individuals worldwide, and its incidence increases with age. Risk factors for AF include hypertension, aging,...
Case Summary
- Atrial fibrillation (AFib) is a supraventricular arrhythmia characterized by uncoordinated atrial electrical activation and ineffective atrial contraction, resulting in irregular fibrillatory waves on ECG. Common causes include hypertension, coronary artery disease, rheumatic heart disease, congenital heart defects, heart failure, myocarditis, and cardiomyopathies. Systemic causes involve hyperthyroidism, obstructive sleep apnea, obesity, diabetes mellitus, chronic kidney failure, and pulmonary embolism.
Speaker Profile

Dr. K. V. Sahasranam
Senior Consultant Cardiologist, Calicut Medical College, KeralaDr. K. V. Sahasranam is a Senior Consultant Cardiologist with extensive experience in the diagnosis and management of cardiovascular diseases.
He is associated with Calicut Medical College and has contributed significantly to clinical cardiology and patient care.
His areas of expertise include coronary artery disease, heart failure, hypertension, arrhythmias, and preventive cardiology.
He is committed to providing evidence-based cardiac care and promoting awareness of cardiovascular health.
Through his clinical experience and academic involvement, he continues to support advancements in cardiology and improved patient outcomes.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.